Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials

Código QR

Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials

Guardado en:

Detalles Bibliográficos
Autores principales:	Hong Huang, Wenhui Xie, Zhuoli Zhang, Siyan Zhan
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/6e711cd71d0e411ebacc98873e930217
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
por: Christopher F Bell, et al.
Publicado: (2021)

An update on belimumab for the treatment of lupus
por: Aikaterini Thanou-Stavraki, et al.
Publicado: (2011)

BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
por: Woori Shin, et al.
Publicado: (2018)

Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison
por: Hermine I Brunner, et al.
Publicado: (2021)

Prevalence of dry eye in patients with systemic lupus erythematosus: a meta-analysis
por: Yan Xie, et al.
Publicado: (2021)

Moulage: "Lupus Erythematosus"
por: Beatrix Patzak
Publicado: (2011)

Netosis in patients with systemic lupus erythematosus
por: V. V. Zhelezko, et al.
Publicado: (2020)

Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
por: Roubi Kilo, et al.
Publicado: (2021)

Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
por: Anselm Mak, et al.
Publicado: (2017)

Celiac disease in patients with systemic lupus erythematosus
por: Zahra Soltani, et al.
Publicado: (2021)

Systemic lupus erythematosus and critical illness polyneuropathy
por: Maria Katkowska, et al.
Publicado: (2021)

Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus
por: Arancha Hevia, et al.
Publicado: (2014)

Inflammatory etiopathogenesis of systemic lupus erythematosus: an update
por: Podolska MJ, et al.
Publicado: (2015)

Correlation between circulating interleukin-18 level and systemic lupus erythematosus: a meta-analysis
por: Mengmeng Xiang, et al.
Publicado: (2021)

Alcohol and Mortality from All Causes
por: RENAUD,SERGE, et al.
Publicado: (2004)

A Case of Systemic Lupus Erythematosus without Antiphospholipid Syndrome Causing Superior Vena Cava Syndrome
por: Vivek Choudhary, et al.
Publicado: (2021)

Emerging B-Cell Therapies in Systemic Lupus Erythematosus
por: Bag-Ozbek A, et al.
Publicado: (2021)

Dermoscopic Appearance of an Annular Subacute Cutaneous Lupus Erythematosus
por: Biswanath Behera, et al.
Publicado: (2021)

Acute mesenteric lymphadenitis revealing systemic lupus erythematosus
por: Salem Bouomrani, et al.
Publicado: (2020)

Transancestral mapping and genetic load in systemic lupus erythematosus
por: Carl D. Langefeld, et al.
Publicado: (2017)

Bullous systemic lupus erythematosus: exceptional and challenging presentation
por: Salem Bouomrani, et al.
Publicado: (2020)

Association between endometriosis and risk of systemic lupus erythematosus
por: Yu-Hsi Fan, et al.
Publicado: (2021)

Canadian workplace experiences of systemic lupus erythematosus (SLE)
por: Ann E Clarke, et al.
Publicado: (2021)

Choroidal thickness changes in systemic lupus erythematosus patients
por: Dias-Santos A, et al.
Publicado: (2019)

Osteomyelitis and septic arthritis in neonatal lupus erythematosus patients
por: Virany Diana, et al.
Publicado: (2022)

Safety of hormonal replacement therapy and oral contraceptives in systemic lupus erythematosus: a systematic review and meta-analysis.
por: Adriana Rojas-Villarraga, et al.
Publicado: (2014)

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus
por: Sarfaraz A. Hasni, et al.
Publicado: (2021)

Neuropsychiatric involvement in systemic lupus erythematosus: A case series
por: Nishtha Gupta, et al.
Publicado: (2021)

B-CELL SUBPOPULATIONS OF PERIPHERAL BLOOD IN SYSTEMIC LUPUS ERYTHEMATOSUS
por: A. I. Budkova, et al.
Publicado: (2017)

Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
por: Michael Sticherling
Publicado: (2011)

The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
por: Xirui Guo, et al.
Publicado: (2021)

Management of systemic lupus erythematosus during pregnancy: challenges and solutions
por: Knight CL, et al.
Publicado: (2017)

Integrative Analysis for Elucidating Transcriptomics Landscapes of Systemic Lupus Erythematosus
por: Haihong Zhang, et al.
Publicado: (2021)

Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus
por: He S, et al.
Publicado: (2021)

Leisure-time physical activity and all-cause mortality.
por: Jouni Lahti, et al.
Publicado: (2014)

Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
por: Eissa IM, et al.
Publicado: (2020)

Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy
por: Helena Idborg, et al.
Publicado: (2021)

Audiologic evaluation in systemic lupus erythematosus patients and impact of hydroxychloroquine therapy
por: Samar Tharwat, et al.
Publicado: (2022)

Subacute cutaneous lupus erythematosus onset preceded by Kikuchi-Fujimoto disease
por: Vito Di Lernia, et al.
Publicado: (2014)

White rosette in discoid lupus erythematosus: a new dermoscopic observation
por: Balachandra S. Ankad, et al.
Publicado: (2017)